HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Merkel Cell Carcinoma

Merkel Cell Carcinoma

Merkel Cell Carcinoma (MCC) is a rare but aggressive form of skin cancer that typically appears as painless, flesh-colored or bluish-red nodules on the skin. Although it accounts for less than 1% of skin cancers, its rapid growth and tendency to metastasize make it challenging to treat. Cancer research in MCC focuses on understanding its molecular pathways and developing targeted therapies. Recent advances include the identification of Merkel cell polyomavirus (MCV) as a potential causative agent, leading to the development of immunotherapies such as checkpoint inhibitors. Additionally, efforts are underway to explore combination therapies and biomarkers for early detection and personalized treatment approaches. Despite progress, further research is needed to improve outcomes for patients with this aggressive malignancy.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp